Euroapi S.A. (LON: 0EAP)

Market Cap	250.55M
Revenue (ttm)	823.49M
Net Income (ttm)	-243.58M
Shares Out	n/a
EPS (ttm)	-2.59
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	713
Average Volume	2,114
Open	3.134
Previous Close	3.162
Day's Range	3.130 - 3.184
52-Week Range	1.889 - 5.792
Beta	0.56
RSI	50.91
Earnings Date	Feb 11, 2025

About Euroapi

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2020
• Employees: 3,329
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0EAP

Financial Performance

In 2023, Euroapi's revenue was 1.02 billion, an increase of 3.87% compared to the previous year's 980.90 million. Losses were -189.70 million, 1164.7% more than in 2022.

Financial numbers in EUR